Top officials for the Food and Drug Administration laid out new requirements for access to updated COVID shots, saying they'd continue to use a streamlined approach to make them available to adults 65 and older as well as children and younger adults with at least one high-risk health problem.

Advisors to the Food and Drug Administration have recommended unanimously that the agency approve the Alzheimer’s drug donanemab.

Quaker said that it has not received any reports of salmonella infections related to the recalled granola products. The full list of recalled foods includes granola oats cereals and Quaker Chewy Bars.

Supporters of abortion rights have filed separate lawsuits challenging abortion pill restrictions in North Carolina and West Virginia. The lawsuits were filed Wednesday.

Changes by the FDA mean patients won't have to schedule in-person exams to get a prescription. That opens the door for more pharmacies to provide the medication. But not everyone will have access.

Harvesters, processors, manufacturers and others in the food chain have three years to comply with the new record keeping system, effective next month

In March, experts who advise the FDA questioned the efficacy of an experimental new drug for ALS. In September, they voted to approve it anyway.

Now, both the Pfizer and the Moderna booster shots can be given five months after the second dose of vaccine — down from six months.

The Food and Drug Administration greenlights the biotech firm's vaccine for emergency use in the U.S. The move bolsters a vast inoculation effort that's already underway.

The Food and Drug Administration says is advising health workers to use "every full dose obtainable" to help speed up the nationwide immunization campaign.

Pfizer and BioNTech's vaccine is the first to receive an emergency authorization from the Food and Drug Administration. Officials say it may be ready for widespread inoculations within days.

The Food and Drug Administration's authorization of a COVID-19 vaccine could come in a day or two, a member of an FDA expert panel says. But he says it may be late 2021 before normalcy returns.

The pharmaceutical giant and partner BioNTech announced Friday that they are submitting a formal request to the Food and Drug Administration, just days after the vaccine was shown to be 95% effective.

The Federal Trade Commission issued warning letters to several companies that marketed an unproven drug to treat COVID-19. Sales of the nonapproved drug, thymosin alpha-1, were first reported by NPR.

An NPR investigation revealed a network of doctors marketing a non-FDA approved drug as a purported treatment for COVID-19. Now, Rep. Raja Krishnamoorthi (D-Ill.) is calling for federal enforcement.